Fiche personne
Territoire
Alsace
Statut
Chercheur
Équipes/plateformes
Equipe Equipe "Génomique fonctionnelle et cancer / Hématopoïèse et leucémogenèse chez la souris"
Projets
Comment le facteur Helios permet de maintenir un génome de bonne qualité pour empêcher le développement de leucémies
2016 - Porteur du projet : Dr KASTNER Philippe
Rôle du facteur de transcription Helios dans le contrôle de la réponse aux dommages de l'ADN dans les cellules souches hématopoïétiques
2016 - Porteur du projet : Dr KASTNER Philippe
Compréhension des voies affectées par la perte d'Ikaros dans les leucémies aiguës lymphobastiques à précurseurs B
2015 - Porteur du projet : Dr KASTNER Philippe
Compréhension du rôle suppresseur de tumeur d'Ikaros dans les leucémies aiguës lymphoblasiques B
2014 - Porteur du projet : Dr KASTNER Philippe
Aquisition d'un système pour l'analyse de l'expression de multiples gènes dans des cellules uniques
2012 - Porteur du projet : Dr KASTNER Philippe
Identification et fonction des mutations d'Ikaros dans les leucémies aiguës lymphoblastiques B humaines
2012 - Porteur du projet : Dr KASTNER Philippe
Identification et ciblage des voies moléculaires associées à la fonction suppresseur de tumeur d'Ikaros dans les leucémies aiguës lymphoblastiques
2011 - Porteur du projet : Dr KASTNER Philippe
Caractérisation du rôle des formes méthylées de CBP/p300 dans la transduction du signal : analyse des « codes » de méthylation de ces HAT dans la différenciation et de leur méthylation aberrante dans le cancer.
2010 - Porteur du projet : Dr GRONEMEYER Hinrich - Partenaire : Pr BERGERAT Jean-Pierre , Dr KASTNER Philippe , Dr NEUVILLE Agnès
Implication des protéines ATF7, CREB et des TAFs associés dans la genèse des mélanomes
2010 - Porteur du projet : Pr CHATTON Bruno - Partenaire : Dr BRINO Laurent , Dr DAVIDSON Irwin , Dr KASTNER Philippe , Dr NEUVILLE Agnès
Exploring the early steps of infection of H-1 oncolytic parvovirus (H1PVRNAI)
2008 - Porteur du projet : Dr MARCHINI Antonio - Partenaire : Dr BRINO Laurent , Dr KASTNER Philippe , Dr MORAS Dino , Dr POCH Olivier , Dr VONESCH Jean-Luc
Mechanism of tumor suppression by the transcriptional repressor Ikaros in T cells: role of the histone lysine methyl-transferases SET1 and SMYD2 (PD Philippe Kastner)
2008 - Porteur du projet : Dr KASTNER Philippe
Prognostic and predictive values of high-resolution molecular DNA markers in non-small cell lung cancers (NSCLC) of IFCT-00-02 trial (Phase III study comparing a preoperative and a perioperative chemotherapy with two different chemotherapy regimens in res (BIO IFCT-00-02 II)
2008 - Porteur du projet : Dr BEAU-FALLER Michèle - Partenaire : Dr KASTNER Philippe , Dr LEGRAIN-JACOBS Michèle , Dr POCH Olivier
Signalisation par l'Acide Rétinoïque et réponses Transcriptionnelles : effets anti- et pro-ONcogéniques (ARTOn)
2008 - Porteur du projet : Dr DAVIDSON Irwin - Partenaire : Dr KASTNER Philippe , Dr POCH Olivier
Study of ubiqitination/deubiquitination of chromatin in tumor cells and the development of small molecule inhibitors that inhibit cell proliferation (UBICAN)
2008 - Porteur du projet : Dr TORA Laszlo - Partenaire : Dr GHNASSIA Jean-Pierre , Dr GIANGRANDE Angela , Pr HAIECH Jacques , Dr HAMICHE Ali , Dr KASTNER Philippe , Dr VAN DORSSELAER Alain , Dr VONESCH Jean-Luc
Understanding the pathways of leukemogenesis controlled by the Ikaros tumor suppressor (Ikaros and ALL)
2008 - Porteur du projet : Dr KASTNER Philippe
Early determination of aggressiveness of primary tumors (RIO2007)
2007 - Porteur du projet : Dr RIO Marie-Christine - Partenaire : Pr ABECASSIS Joseph , Pr BIREMBAUT Philippe , Pr DIEBOLD Marie-Danièle , Dr FREUND Jean-Noël , Dr GAUB Marie-Pierre , Dr GHNASSIA Jean-Pierre , Dr GUERIN Eric , Pr HAIECH Jacques , Pr JEANNESSON Pierre , Dr KASTNER Philippe , Pr MANFAIT Michel , Pr MAQUART François-Xavier , Dr NEUVILLE Agnès , Dr OREND Gertraud , Pr PLENAT François , Dr VAN DORSSELAER Alain , Pr VIGNAUD Jean-Michel , Dr VOEGEL Jean-Claude , Dr WASYLYK Bohdan
Publications
IKAROS Family Transcription Factors in Lymphocyte Differentiation and Function.
Kastner P, Chan S
Adv Exp Med Biol. 2024 ;1459:33-52
Evolution of the Ikaros family transcription factors: From a deuterostome ancestor to humans.
Kastner P, Aukenova A, Chan S
Biochem Biophys Res Commun. 2023 12 18;694:149399
Ikaros is a principal regulator of Aire mTEC homeostasis, thymic mimetic cell diversity, and central tolerance.
Sin JH, Sucharov J, Kashyap S, Wang Y, Proekt I, Liu X, Parent AV, Gupta A, Kastner P, Chan S, Gardner JM, Ntranos V, Miller CN, Anderson MS, Schjerven H, Waterfield MR
Sci Immunol. 2023 10 27;8(88):eabq3109
CD4 regulatory T cells lacking Helios and Eos.
Polak K, Marchal P, Taroni C, Ebel C, Kirstetter P, Kastner P, Chan S
Biochem Biophys Res Commun. 2023 06 28;674:83-89
Helios represses megakaryocyte priming in hematopoietic stem and progenitor cells.
Cova G, Taroni C, Deau MC, Cai Q, Mittelheisser V, Philipps M, Jung M, Cerciat M, Le Gras S, Thibault-Carpentier C, Jost B, Carlsson L, Thornton AM, Shevach EM, Kirstetter P, Kastner P, Chan S
J Exp Med. 2021 Oct 4;218(10):
Ikaros deficiency is associated with aggressive BCR-ABL1 B cell precursor acute lymphoblastic leukemia independent of the lineage and developmental origin.
Simand C, Keime C, Cayé A, Arfeuille C, Passet M, Kim R, Cavé H, Clappier E, Kastner P, Chan S, Heizmann B
Haematologica. 2021 Sep 30;:
CD4 T cells require Ikaros to inhibit their differentiation toward a pathogenic cell fate.
Bernardi C, Maurer G, Ye T, Marchal P, Jost B, Wissler M, Maurer U, Kastner P, Chan S, Charvet C
Proc Natl Acad Sci U S A. 2021 Apr 27;118(17):
Ikaros antagonizes DNA binding by STAT5 in pre-B cells.
Heizmann B, Le Gras S, Simand C, Marchal P, Chan S, Kastner P
PLoS One. 2020 ;15(11):e0242211
Large deletions of the 5' region of IKZF1 lead to haploinsufficiency in B-cell precursor acute lymphoblastic leukaemia.
Morel G, Deau MC, Simand C, Caye-Eude A, Arfeuille C, Ittel A, Miguet L, Mauvieux L, Herbrecht R, Paillard C, Strullu M, Cavé H, Chan S, Kastner P, Heizmann B
Br. J. Haematol.. 2019 May 30;:
Ikaros cooperates with Notch activation and antagonizes TGFβ signaling to promote pDC development.
Mastio J, Simand C, Cova G, Kastner P, Chan S, Kirstetter P
PLoS Genet.. 2018 Jul;14(7):e1007485
The Ikaros family in lymphocyte development.
Heizmann B, Kastner P, Chan S
Curr. Opin. Immunol.. 2017 Dec 23;51:14-23
Therapeutical modulation of plasmacytoid dendritic cells in experimental arthritis.
Nehmar R, Alsaleh G, Voisin B, Flacher V, Mariotte A, Saferding V, Puchner A, Niederreiter B, Vandamme T, Schabbauer G, Kastner P, Chan S, Kirstetter P, Holcmann M, Mueller C, Sibilia J, Bahram S, Blüml S, Georgel P
. 2017 Aug;:
Helios expression coordinates the development of a subset of striatopallidal medium spiny neurons.
Martín-Ibáñez R, Pardo M, Giralt A, Miguez A, Guardia I, Marion-Poll L, Herranz C, Esgleas M, Barriga GG, Edel MJ, Vicario-Abejón C, Alberch J, Girault JA, Chan S, Kastner P, Canals JM
Development. 2017 Mar;:
Ikaros Inhibits Group 3 Innate Lymphoid Cell Development and Function by Suppressing the Aryl Hydrocarbon Receptor Pathway.
Li S, Heller JJ, Bostick JW, Lee A, Schjerven H, Kastner P, Chan S, Chen ZE, Zhou L
Immunity. 2016 Jul;45(1):185-97
Ikaros Is a Negative Regulator of B1 Cell Development and Function.
Macias-Garcia A, Heizmann B, Sellars M, Marchal P, Dali H, Pasquali JL, Muller S, Kastner P, Chan S
J. Biol. Chem.. 2016 Apr;291(17):9073-86
Ikaros limits follicular B cell activation by regulating B cell receptor signaling pathways.
Heizmann B, Sellars M, Macias-Garcia A, Chan S, Kastner P
Biochem. Biophys. Res. Commun.. 2016 Feb;470(3):714-20
Sumoylation Inhibits the Growth Suppressive Properties of Ikaros.
Apostolov A, Litim-Mecheri I, Oravecz A, Goepp M, Kirstetter P, Marchal P, Ittel A, Mauvieux L, Chan S, Kastner P
PLoS ONE. 2016 ;11(6):e0157767
Stable inhibitory activity of regulatory T cells requires the transcription factor Helios.
Kim HJ, Barnitz RA, Kreslavsky T, Brown FD, Moffett H, Lemieux ME, Kaygusuz Y, Meissner T, Holderried TA, Chan S, Kastner P, Haining WN, Cantor H
Science. 2015 Oct 16;350(6258):334-9
IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951.
Clappier E, Grardel N, Bakkus M, Rapion J, De Moerloose B, Kastner P, Caye A, Vivent J, Costa V, Ferster A, Lutz P, Mazingue F, Millot F, Plantaz D, Plat G, Plouvier E, Poiree M, Sirvent N, Uyttebroeck A, Yakouben K, Girard S, Dastugue N, Suciu S, Benoit Y, Bertrand Y, Cave H
Leukemia. 2015 Jun 8
Ikaros mediates gene silencing in T cells through Polycomb repressive complex 2.
Oravecz A, Apostolov A, Polak K, Jost B, Le Gras S, Chan S, Kastner P
Nat Commun. 2015 Nov 9;6:8823
The tumor suppressor Ikaros shapes the repertoire of notch target genes in T cells.
Geimer Le Lay AS, Oravecz A, Mastio J, Jung C, Marchal P, Ebel C, Dembele D, Jost B, Le Gras S, Thibault C, Borggrefe T, Kastner P, Chan S
Sci Signal. 2014 Mar 18;7(317):ra28
Fold change rank ordering statistics: a new method for detecting differentially expressed genes.
Dembele D, Kastner P
BMC Bioinformatics. 2014 Jan 15;15:14
Ikaros is absolutely required for pre-B cell differentiation by attenuating IL-7 signals.
Heizmann B, Kastner P, Chan S
J Exp Med. 2013 Dec 16;210(13):2823-32
beta-Catenin activation synergizes with Pten loss and Myc overexpression in Notch-independent T-ALL.
Kaveri D, Kastner P, Dembele D, Nerlov C, Chan S, Kirstetter P
Blood. 2013 Aug 1;122(5):694-704
Biclonal and biallelic deletions occur in 20% of B-ALL cases with IKZF1 mutations.
Dupuis A, Gaub MP, Legrain M, Drenou B, Mauvieux L, Lutz P, Herbrecht R, Chan S, Kastner P
Leukemia. 2013 Feb;27(2):503-7
Function of Ikaros as a tumor suppressor in B cell acute lymphoblastic leukemia.
Kastner P, Dupuis A, Gaub MP, Herbrecht R, Lutz P, Chan S
Am J Blood Res. 2013;3(1):1-13
A multiply redundant genetic switch 'locks in' the transcriptional signature of regulatory T cells.
Fu W, Ergun A, Lu T, Hill JA, Haxhinasto S, Fassett MS, Gazit R, Adoro S, Glimcher L, Chan S, Kastner P, Rossi D, Collins JJ, Mathis D, Benoist C
Nat Immunol. 2012 Oct;13(10):972-80
Pivotal role of plasmacytoid dendritic cells in inflammation and NK-cell responses after TLR9 triggering in mice.
Guillerey C, Mouries J, Polo G, Doyen N, Law HK, Chan S, Kastner P, Leclerc C, Dadaglio G
Blood. 2012 Jul 5;120(1):90-9
Ikaros in B cell development and function.
Sellars M, Kastner P, Chan S
World J Biol Chem. 2011 Jun 26;2(6):132-9
Role of Ikaros in T-cell acute lymphoblastic leukemia.
Kastner P, Chan S
World J Biol Chem. 2011 Jun 26;2(6):108-14
Helios is associated with CD4 T cells differentiating to T helper 2 and follicular helper T cells in vivo independently of Foxp3 expression.
Serre K, Benezech C, Desanti G, Bobat S, Toellner KM, Bird R, Chan S, Kastner P, Cunningham AF, Maclennan IC, Mohr E
PLoS One. 2011;6(6):e20731
Deletion-based mechanisms of Notch1 activation in T-ALL: key roles for RAG recombinase and a conserved internal translational start site in Notch1.
Ashworth TD, Pear WS, Chiang MY, Blacklow SC, Mastio J, Xu L, Kelliher M, Kastner P, Chan S, Aster JC
Blood. 2010 Dec 16;116(25):5455-64
Bcl11b represses a mature T-cell gene expression program in immature CD4(+)CD8(+) thymocytes.
Kastner P, Chan S, Vogel WK, Zhang LJ, Topark-Ngarm A, Golonzhka O, Jost B, Le Gras S, Gross MK, Leid M
Eur J Immunol. 2010 Aug;40(8):2143-54.
Haploinsufficiency of the IKZF1 (IKAROS) tumor suppressor gene cooperates with BCR-ABL in a transgenic model of acute lymphoblastic leukemia.
Virely C, Moulin S, Cobaleda C, Lasgi C, Alberdi A, Soulier J, Sigaux F, Chan S, Kastner P, Ghysdael J
Leukemia. 2010 Jun;24(6):1200-4
Genetic inactivation of Ikaros is a rare event in human T-ALL.
Marcais A, Jeannet R, Hernandez L, Soulier J, Sigaux F, Chan S, Kastner P
Leuk Res. 2010 Apr;34(4):426-9
MafB restricts M-CSF-dependent myeloid commitment divisions of hematopoietic stem cells.
Sarrazin S, Mossadegh-Keller N, Fukao T, Aziz A, Mourcin F, Vanhille L, Kelly Modis L, Kastner P, Chan S, Duprez E, Otto C, Sieweke MH
Cell. 2009 Jul 23;138(2):300-13.
Ikaros controls isotype selection during immunoglobulin class switch recombination.
Sellars M, Reina-San-Martin B, Kastner P, Chan S
J Exp Med. 2009 May 11;206(5):1073-87
Plasmacytoid dendritic cells are dispensable during primary influenza virus infection.
Wolf AI, Buehler D, Hensley SE, Cavanagh LL, Wherry EJ, Kastner P, Chan S, Weninger W
J Immunol. 2009 Jan 15;182(2):871-9.
Ikaros represses the transcriptional response to Notch signaling in T-cell development.
Kleinmann E, Geimer Le Lay AS, Sellars M, Kastner P, Chan S
Mol Cell Biol. 2008 Dec;28(24):7465-75
Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling.
Robbins SH, Walzer T, Dembele D, Thibault C, Defays A, Bessou G, Xu H, Vivier E, Sellars M, Pierre P, Sharp FR, Chan S, Kastner P, Dalod M
Genome Biol. 2008 Jan 24;9(1):R17.
PU.1: a crucial and versatile player in hematopoiesis and leukemia.
Kastner P, Chan S
Int J Biochem Cell Biol. 2008;40(1):22-7
Reciprocal activation of GATA-1 and PU.1 marks initial specification of hematopoietic stem cells into myeloerythroid and myelolymphoid lineages.
Arinobu Y, Mizuno S, Chong Y, Shigematsu H, Iino T, Iwasaki H, Graf T, Mayfield R, Chan S, Kastner P, Akashi K
Cell Stem Cell. 2007 Oct 11;1(4):416-27.
Ikaros is required for plasmacytoid dendritic cell differentiation.
Allman D, Dalod M, Asselin-Paturel C, Delale T, Robbins SH, Trinchieri G, Biron CA, Kastner P, Chan S
Blood. 2006 Dec 15;108(13):4025-34
[Notch activation during T-cell leukemogenesis in Ikaros-deficient mice].
Kastner P, Chan S
Med Sci (Paris). 2006 Aug-Sep;22(8-9):708-10.
Absence of the steroid receptor coactivator-3 induces B-cell lymphoma.
Coste A, Antal MC, Chan S, Kastner P, Mark M, O'Malley BW, Auwerx J
EMBO J. 2006 Jun 7;25(11):2453-64
An open-access long oligonucleotide microarray resource for analysis of the human and mouse transcriptomes.
Le Brigand K, Russell R, Moreilhon C, Rouillard JM, Jost B, Amiot F, Magnone V, Bole-Feysot C, Rostagno P, Virolle V, Defamie V, Dessen P, Williams G, Lyons P, Rios G, Mari B, Gulari E, Kastner P, Gidrol X, Freeman TC, Barbry P
Nucleic Acids Res. 2006 Jul 19;34(12):e87.
Notch activation is an early and critical event during T-Cell leukemogenesis in Ikaros-deficient mice.
Dumortier A, Jeannet R, Kirstetter P, Kleinmann E, Sellars M, dos Santos NR, Thibault C, Barths J, Ghysdael J, Punt JA, Kastner P, Chan S
Mol Cell Biol. 2006 Jan;26(1):209-20.
MyD88-dependent and -independent murine cytomegalovirus sensing for IFN-alpha release and initiation of immune responses in vivo.
Delale T, Paquin A, Asselin-Paturel C, Dalod M, Brizard G, Bates EE, Kastner P, Chan S, Akira S, Vicari A, Biron CA, Trinchieri G, Briere F
J Immunol. 2005 Nov 15;175(10):6723-32.
Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation.
Iwasaki H, Somoza C, Shigematsu H, Duprez EA, Iwasaki-Arai J, Mizuno S, Arinobu Y, Geary K, Zhang P, Dayaram T, Fenyus ML, Elf S, Chan S, Kastner P, Huettner CS, Murray R, Tenen DG, Akashi K
Blood. 2005 Sep 1;106(5):1590-600
Visualizing PU.1 activity during hematopoiesis.
Back J, Allman D, Chan S, Kastner P
Exp Hematol. 2005 Apr;33(4):395-402.
Enhanced bone formation in lipodystrophic PPARgamma(hyp/hyp) mice relocates haematopoiesis to the spleen.
Cock TA, Back J, Elefteriou F, Karsenty G, Kastner P, Chan S, Auwerx J
EMBO Rep. 2004 Oct;5(10):1007-12
PU.1 determines the self-renewal capacity of erythroid progenitor cells.
Back J, Dierich A, Bronn C, Kastner P, Chan S
Blood. 2004 May 15;103(10):3615-23
Selective ablation of retinoid X receptor alpha in hepatocytes impairs their lifespan and regenerative capacity.
Imai T, Jiang M, Kastner P, Chambon P, Metzger D
Proc. Natl. Acad. Sci. U.S.A.. 2001 Apr;98(8):4581-6
Differential expression of retinoid receptors in the adult mouse central nervous system.
Krezel W, Kastner P, Chambon P
Neuroscience. 1999 ;89(4):1291-300
Absence of thyroid hormone receptor beta-retinoid X receptor interactions in auditory function and in the pituitary-thyroid axis.
Barros AC, Erway LC, Krezel W, Curran T, Kastner P, Chambon P, Forrest D
Neuroreport. 1998 Sep;9(13):2933-7
Impaired locomotion and dopamine signaling in retinoid receptor mutant mice.
Krezel W, Ghyselinck N, Samad TA, Dupé V, Kastner P, Borrelli E, Chambon P
Science. 1998 Feb;279(5352):863-7
Mesectoderm is a major target of retinoic acid action.
Mark M, Ghyselinck NB, Kastner P, Dupé V, Wendling O, Krezel W, Mascrez B, Chambon P
Eur. J. Oral Sci.. 1998 Jan;106 Suppl 1:24-31
Genetic evidence that the retinoid signal is transduced by heterodimeric RXR/RAR functional units during mouse development.
Kastner P, Mark M, Ghyselinck N, Krezel W, Dupé V, Grondona JM, Chambon P
Development. 1997 Jan;124(2):313-26
[Genetic control of the development by retinoic acid].
Mark M, Kastner P, Ghyselinck NB, Krezel W, Dupé V, Chambon P
C. R. Seances Soc. Biol. Fil.. 1997 ;191(1):77-90
RXR gamma null mice are apparently normal and compound RXR alpha +/-/RXR beta -/-/RXR gamma -/- mutant mice are viable.
Krezel W, Dupé V, Mark M, Dierich A, Kastner P, Chambon P
Proc. Natl. Acad. Sci. U.S.A.. 1996 Aug;93(17):9010-4
Abnormal spermatogenesis in RXR beta mutant mice.
Kastner P, Mark M, Leid M, Gansmuller A, Chin W, Grondona JM, Décimo D, Krezel W, Dierich A, Chambon P
Genes Dev.. 1996 Jan;10(1):80-92